日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

HER2 Protein Overexpression, mRNA Expression, and DNA Amplification Across Solid Tumors: Comparison of Next-Generation Sequencing-Based Assays With Immunohistochemistry

HER2蛋白过表达、mRNA表达和DNA扩增在实体瘤中的分布:基于新一代测序的检测方法与免疫组织化学的比较

Nagamine, Michiko; Fujisawa, Takao; Sakamoto, Naoya; Nakamura, Yoshiaki; Kadowaki, Shigenori; Ueno, Makoto; Boku, Shogen; Komatsu, Yoshito; Oki, Eiji; Makiyama, Akitaka; Nonomura, Norio; Morizane, Chigusa; Watari, Hidemichi; Okano, Susumu; Iwata, Hiroji; Namikawa, Kenjiro; Hatanaka, Yutaka; Hatanaka, Kanako C; Taguchi, Kenichi; Spetzler, David; Radovich, Milan; Magee, Daniel; Yoshino, Takayuki; Oberley, Matthew; Kuwata, Takeshi

Abdominal Wall Abscess after Prophylactic Percutaneous Endoscopic Gastrostomy Placement in a Patient Undergoing Chemoradiotherapy for Laryngeal Cancer

喉癌患者接受放化疗期间预防性经皮内镜胃造瘘术后发生腹壁脓肿

Okamoto, Ryuji; Sunakawa, Hironori; Owaki, Yuji; Oka, Hiroaki; Hoshi, Yuta; Okano, Susumu; Yano, Tomonori

Landscape Analysis of CLDN18 Expression and Isoform Distribution in Solid Tumors: Insights From MONSTAR-SCREEN-2 Study.

实体瘤中 CLDN18 表达和亚型分布的景观分析:来自 MONSTAR-SCREEN-2 研究的启示

Hashimoto Tadayoshi, Iida Naoko, Nakamura Yoshiaki, Nonomura Norio, Morizane Chigusa, Iwata Hiroji, Okano Susumu, Yamagami Wataru, Yamazaki Naoya, Kadowaki Shigenori, Ueno Makoto, Boku Shogen, Oki Eiji, Komatsu Yoshito, Yuki Satoshi, Makiyama Akitaka, Ogata Takatsugu, Takahashi Naoki, Okano Naohiro, Nishina Tomohiro, Sakamoto Naoya, Kuwata Takeshi, Yamashita Riu, Shibuki Taro, Imai Mitsuho, Fujisawa Takao, Bando Hideaki, Shitara Kohei, Yoshino Takayuki

Resistance mechanism to pembrolizumab in DEK-AFF2 fusion-associated sinonasal squamous cell carcinoma

DEK-AFF2融合相关鼻窦鳞状细胞癌对帕博利珠单抗的耐药机制

Boku, Shogen; Fujisawa, Takao; Kadowaki, Shigenori; Satake, Hironaga; Yasui, Hisateru; Ohtsubo, Koushiro; Shimizu, Yasushi; Otsuka, Tomoyuki; Kuze, Bunya; Yamashita, Riu; Shibuki, Taro; Nakamura, Yoshiaki; Bando, Hideaki; Yoshino, Takayuki; Radovich, Milan; Okano, Susumu

The SCRUM-MONSTAR Cancer-Omics Ecosystem: Striving for a Quantum Leap in Precision Medicine

SCRUM-MONSTAR癌症组学生态系统:力求在精准医学领域实现质的飞跃

Hashimoto, Tadayoshi; Nakamura, Yoshiaki; Fujisawa, Takao; Imai, Mitsuho; Shibuki, Taro; Iida, Naoko; Ozaki, Hiroshi; Nonomura, Norio; Morizane, Chigusa; Iwata, Hiroji; Okano, Susumu; Yamagami, Wataru; Yamazaki, Naoya; Kadowaki, Shigenori; Taniguchi, Hiroya; Ueno, Makoto; Boku, Shogen; Oki, Eiji; Komatsu, Yoshito; Yuki, Satoshi; Makiyama, Akitaka; Otsuka, Tomoyuki; Hara, Hiroki; Okano, Naohiro; Nishina, Tomohiro; Sakamoto, Yasutoshi; Miki, Izumi; Kobayashi, Shin; Yuda, Junichiro; Kageyama, Shun-Ichiro; Nagamine, Michiko; Sakashita, Shingo; Sakamoto, Naoya; Yamashita, Riu; Koga, Yoshikatsu; Bando, Hideaki; Ishii, Genichiro; Kuwata, Takeshi; Park, Woong-Yang; Ohtsu, Atsushi; Yoshino, Takayuki

Induction chemotherapy with paclitaxel, carboplatin, and cetuximab (PCE) followed by chemoradiotherapy for unresectable locoregional recurrence after curative surgery in patients with squamous cell carcinoma of the head and neck

对于头颈部鳞状细胞癌患者,根治性手术后出现无法切除的局部区域复发,可采用紫杉醇、卡铂和西妥昔单抗(PCE)方案进行诱导化疗,随后进行放化疗。

Sato, Masanobu; Enokida, Tomohiro; Fujisawa, Takao; Okano, Susumu; Takeshita, Naohiro; Tanaka, Nobukazu; Tanaka, Hideki; Motegi, Atsushi; Zenda, Sadamoto; Shinozaki, Takeshi; Matsuura, Kazuto; Hayashi, Ryuichi; Akimoto, Tetsuo; Tahara, Makoto

Efficacy of anti-PD-1 monotherapy for recurrent or metastatic olfactory neuroblastoma

抗PD-1单药治疗复发性或转移性嗅神经母细胞瘤的疗效

Hoshi, Yuta; Enokida, Tomohiro; Tamura, Shingo; Nakashima, Torahiko; Okano, Susumu; Fujisawa, Takao; Sato, Masanobu; Wada, Akihisa; Tanaka, Hideki; Takeshita, Naohiro; Tanaka, Nobukazu; Onaga, Ryutaro; Kishida, Takuma; Uryu, Hideoki; Sakashita, Shingo; Asakage, Takahiro; Tahara, Makoto

Impact of lenvatinib-induced proteinuria and renal dysfunction in patients with thyroid cancer

乐伐替尼诱导的蛋白尿和肾功能障碍对甲状腺癌患者的影响

Shibutani, Yuma; Suzuki, Shinya; Sagara, Atsunobu; Enokida, Tomohiro; Okano, Susumu; Fujisawa, Takao; Sato, Fumiaki; Yumoto, Tetsuro; Sano, Motohiko; Kawasaki, Toshikatsu; Tahara, Makoto

A pharmacist-led opioid de-escalation program after completion of chemoradiotherapy in locally advanced head and neck cancer

局部晚期头颈癌患者完成放化疗后,由药剂师主导的阿片类药物减量方案

Horinouchi, Ai; Enokida, Tomohiro; Suzuki, Shinya; Kamata, Hayato; Kaneko, Asumi; Matsuyama, Chihiro; Fujisawa, Takao; Ueda, Yuri; Ito, Kazue; Okano, Susumu; Kawasaki, Toshikatsu; Tahara, Makoto

Planned drug holidays during treatment with lenvatinib for radioiodine-refractory differentiated thyroid cancer: a retrospective study

计划在接受乐伐替尼治疗放射性碘难治性分化型甲状腺癌期间暂停用药:一项回顾性研究

Matsuyama, Chihiro; Enokida, Tomohiro; Ueda, Yuri; Suzuki, Shinya; Fujisawa, Takao; Ito, Kazue; Okano, Susumu; Tahara, Makoto